Sarcopenia
Conditions
Interventions
Control Group:Control group receives free exercise combined with medication: Medication: Caltrate D (Wyeth Pharmaceuticals, 600mg calcium/tablet, 125IU Vit D/tablet), 1 tablet daily after breakfast fo
Experimental Group:Experimental group receives modified Yijin Jing exercises combined with meridian point Tuina: Modified Yijin Jing exercise prescription: Based on the National Sports Administration'
Sponsors
Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Integrated Chinese and Western Medicine Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet diagnostic criteria for elderly sarcopenia; (2) Age =60 and =80 years, gender unrestricted; (3) No contraindications for Tuina; (4) Possess normal communication and cognitive abilities; (5) Voluntarily participate in the study and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Suffering from diabetes, heart disease, liver/kidney dysfunction, immune system diseases, infectious diseases, or in acute phase of chronic diseases; (2) Lacking independent mobility; (3) Implanted electronic devices or metal in body; (4) Received any sarcopenia-related treatment within 3 months prior to study; (5) Participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Grip strength; | — |
Secondary
| Measure | Time frame |
|---|---|
| DXA Body Composition Analysis;Modified Falls Efficacy Scale (MFES);Timed Up & Go Test (TUGT);Biomechanical Indicators; | — |
Countries
China
Contacts
Public ContactYan Zhen
Shanghai University of Traditional Chinese Medicine Affiliated Yueyang Integrated Chinese and Western Medicine Hospital
Outcome results
None listed